Omalizumab-A review
Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria.
Saved in:
Main Authors: | , , , , |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE). The US FDA has approved this molecule for chronic urticaria. |
---|---|
Item Description: | 0019-5154 1998-3611 10.4103/0019-5154.160490 |